Cargando…

Mitochondrial Associated Ubiquitin Fold Modifier-1 Mediated Protein Conjugation in Leishmania donovani

In this report, we demonstrate the existence of the ubiquitin fold modifier-1 (Ufm1) and its conjugation pathway in trypanosomatid parasite Leishmania donovani. LdUfm1 is activated by E1-like enzyme LdUba5. LdUfc1 (E2) specifically interacted with LdUfm1 and LdUba5 to conjugate LdUfm1 to proteinaceo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gannavaram, Sreenivas, Sharma, Paresh, Duncan, Robert C., Salotra, Poonam, Nakhasi, Hira L.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3021533/ https://www.ncbi.nlm.nih.gov/pubmed/21264253 http://dx.doi.org/10.1371/journal.pone.0016156

Ejemplares similares

Deletion of Ubiquitin Fold Modifier Protein Ufm1 Processing Peptidase Ufsp in L. donovani Abolishes Ufm1 Processing and Alters Pathogenesis
por: Gannavaram, Sreenivas, et al.
Publicado: (2014)

Biomarkers of Safety and Immune Protection for Genetically Modified Live Attenuated Leishmania Vaccines Against Visceral Leishmaniasis – Discovery and Implications
por: Gannavaram, Sreenivas, et al.
Publicado: (2014)

Immunization with Live Attenuated Leishmania donovani Centrin(−/−) Parasites Is Efficacious in Asymptomatic Infection
por: Ismail, Nevien, et al.
Publicado: (2017)

Whole genome sequencing of live attenuated Leishmania donovani parasites reveals novel biomarkers of attenuation and enables product characterization
por: Gannavaram, Sreenivas, et al.
Publicado: (2017)

Immunity to Visceral Leishmaniasis Using Genetically Defined Live-Attenuated Parasites
por: Selvapandiyan, Angamuthu, et al.
Publicado: (2012)

Gene deleted live attenuated Leishmania vaccine candidates against visceral leishmaniasis elicit pro-inflammatory cytokines response in human PBMCs
por: Avishek, Kumar, et al.
Publicado: (2016)

Centrin-Deleted Leishmania donovani Parasites Help CD4(+) T Cells to Acquire Th1 Phenotype and Multi-Functionality Through Downregulation of CD200–CD200R Immune Inhibitory Axis
por: Singh, Rakesh K., et al.
Publicado: (2018)

Identification and Characterization of Genes Involved in Leishmania Pathogenesis: The Potential for Drug Target Selection
por: Duncan, Robert, et al.
Publicado: (2011)

Production of leishmanin skin test antigen from Leishmania donovani for future reintroduction in the field
por: Dey, Ranadhir, et al.
Publicado: (2023)

Leishmania donovani Argininosuccinate Synthase Is an Active Enzyme Associated with Parasite Pathogenesis
por: Lakhal-Naouar, Ines, et al.
Publicado: (2012)

Modulation of Innate Immune Mechanisms to Enhance Leishmania Vaccine-Induced Immunity: Role of Coinhibitory Molecules
por: Gannavaram, Sreenivas, et al.
Publicado: (2016)

Intradermal Immunization of Leishmania donovani Centrin Knock-Out Parasites in Combination with Salivary Protein LJM19 from Sand Fly Vector Induces a Durable Protective Immune Response in Hamsters
por: Fiuza, Jacqueline Araújo, et al.
Publicado: (2016)

Genomic and Transcriptomic Analysis for Identification of Genes and Interlinked Pathways Mediating Artemisinin Resistance in Leishmania donovani
por: Ghosh, Sushmita, et al.
Publicado: (2020)

Live Attenuated Leishmania donovani Centrin Knock Out Parasites Generate Non-inferior Protective Immune Response in Aged Mice against Visceral Leishmaniasis
por: Bhattacharya, Parna, et al.
Publicado: (2016)

Toll-like Receptor-9 (TLR-9) Signaling Is Crucial for Inducing Protective Immunity following Immunization with Genetically Modified Live Attenuated Leishmania Parasites
por: Bhattacharya, Parna, et al.
Publicado: (2023)

Proteomic Analysis of Leishmania donovani Membrane Components Reveals the Role of Activated Protein C Kinase in Host-Parasite Interaction
por: Verma, Sandeep, et al.
Publicado: (2021)

The History of Live Attenuated Centrin Gene-Deleted Leishmania Vaccine Candidates
por: Volpedo, Greta, et al.
Publicado: (2022)

Dermotropic Leishmania donovani in Sri Lanka: visceralizing potential in clinical and preclinical studies
por: KARIYAWASAM, K. K. G. D. U. L., et al.
Publicado: (2018)

Transcriptome profiling identifies genes/pathways associated with experimental resistance to paromomycin in Leishmania donovani
por: Verma, Aditya, et al.
Publicado: (2017)

Application of rapid in vitro co-culture system of macrophages and T-cell subsets to assess the immunogenicity of dogs vaccinated with live attenuated Leishmania donovani centrin deleted parasites (LdCen(−/−))
por: Viana, Kelvinson Fernandes, et al.
Publicado: (2016)

Ly6C(hi) inflammatory monocytes promote susceptibility to Leishmania donovani infection
por: Terrazas, Cesar, et al.
Publicado: (2017)

Role of CD8(+) T cells in protection against Leishmania donovani infection in healed Visceral Leishmaniasis individuals
por: Kaushal, Himanshu, et al.
Publicado: (2014)

Leishmania mexicana centrin knockout parasites promote M1-polarizing metabolic changes
por: Volpedo, Greta, et al.
Publicado: (2023)

Leishmania major centrin knock-out parasites reprogram tryptophan metabolism to induce a pro-inflammatory response
por: Oljuskin, Timur, et al.
Publicado: (2023)

Increased miltefosine tolerance in clinical isolates of Leishmania donovani is associated with reduced drug accumulation, increased infectivity and resistance to oxidative stress
por: Deep, Deepak Kumar, et al.
Publicado: (2017)

Leishmania Major Centrin Gene-Deleted Parasites Generate Skin Resident Memory T-Cell Immune Response Analogous to Leishmanization
por: Ismail, Nevien, et al.
Publicado: (2022)

miR-21 Expression Determines the Early Vaccine Immunity Induced by LdCen(−/−) Immunization
por: Gannavaram, Sreenivas, et al.
Publicado: (2019)

Programmed cell death in Leishmania: biochemical evidence and role in parasite infectivity
por: Gannavaram, Sreenivas, et al.
Publicado: (2012)

Neutrophil-dendritic cell interaction plays an important role in live attenuated Leishmania vaccine induced immunity
por: Bhattacharya, Parna, et al.
Publicado: (2022)

LEISHMANIA DONOVANI IN THE PERIPHERAL BLOOD
por: Young, Charles W., et al.
Publicado: (1923)

Genetic diversity of Leishmania donovani that causes cutaneous leishmaniasis in Sri Lanka: a cross sectional study with regional comparisons
por: Kariyawasam, Udeshika Lakmini, et al.
Publicado: (2017)

Field-Deployable Treatments For Leishmaniasis: Intrinsic Challenges, Recent Developments and Next Steps
por: Pacheco-Fernandez, Thalia, et al.
Publicado: (2023)

Centrin-deficient Leishmania mexicana confers protection against Old World visceral leishmaniasis
por: Karmakar, Subir, et al.
Publicado: (2022)

CRISPR-Cas9-Mediated Genome Editing in Leishmania donovani
por: Zhang, Wen-Wei, et al.
Publicado: (2015)

Proteomic analysis of the secretome of Leishmania donovani
por: Silverman, J Maxwell, et al.
Publicado: (2008)

Surface antigens of Leishmania donovani promastigotes
Publicado: (1983)

Vaccine Development Against Leishmania donovani
por: Das, Amrita, et al.
Publicado: (2012)

Leishmania donovani bodies in bone marrow
por: Ali, Natasha, et al.
Publicado: (2014)

Revival of Leishmanization and Leishmanin
por: Pacheco-Fernandez, Thalia, et al.
Publicado: (2021)

Stage-specific expression of the mitochondrial co-chaperonin of Leishmania donovani, CPN10
por: Zamora-Veyl, Fanny Beatriz, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_vo9mj5mrjeeq0g8rdou7q0ub90